Endophilin-A1 (SH3G2) (Middle Region) Peptid
SH3G2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle SH3G2 Produkte
- SH3G2 (Endophilin-A1 (SH3G2))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SH3GL2 antibody (Catalog #: ARP56550_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SH3G2 (Endophilin-A1 (SH3G2))
- Hintergrund
-
SH3GL2 is implicated in synaptic vesicle endocytosis. SH3GL2 may recruit other proteins to membranes with high curvature.
Alias Symbols: CNSA2, EEN-B1, FLJ20276, FLJ25015, SH3D2A, SH3P4
Protein Interaction Partner: ADRB1,SH3KBP1,ACTG1,ADAM15,ADRB1,AMPH,ATXN2,BIN1,DNM1,EGFL6,EMD,ERH,HLA-DQA1,IL6,ITCH,MAP4K3,PAK2,PDCD6IP,SH3GL2,SH3GL3,SH3KBP1,SLC17A7,SYNJ1,TCEA2,ACTG1,ADAM15,ADAM19,ADAM9,AMPH,BIN1,CBL,DNM1,EGFL6,EMD,ERH,HLA-DQA1,IL6,SH3KBP1,SYN1,SYNJ1,SYNJ2,TCEA2
Protein Size: 352 - Molekulargewicht
- 40 kDa
- Gen-ID
- 6456
- NCBI Accession
- NM_003026, NP_003017
- UniProt
- Q99962
-
Sie sind hier:
